The term “oligometastatic prostate cancer” refers to a heterogeneous group of disease states
currently defined solely on the basis of clinical features. Oligorecurrent disease, de novo …

Simple Summary Radiolabeled choline and PSMA PET have been largely tested in the
initial staging of prostate cancer and for biochemical recurrence. Moreover, diverse data are …

Background Due to improved imaging sensitivity, the term “oligometastatic” prostate cancer
disease is diagnosed more often, leading to an increasing interest in metastasis-directed …

Background and purpose Patients were treated at our institute for single and multiple lymph
node oligometastases on the 1.5 T MR-linac since August 2018. The superior soft-tissue …

Purpose We assessed the outcomes of stereotactic body radiotherapy (SBRT) to treat
oligoprogressive castration-resistant prostate cancer (CRPC) patients with≤ 5 lesions using …

In accordance with the spectrum theory of metastatic disease, an oligometastatic clinical
state has been proposed as an intermediary step along the natural history of cancer with few …

Context Next-generation imaging includes positron emission tomography (PET) imaging
and whole-body magnetic resonance imaging (wbMRI) including diffusion-weighted …

Technological advances in radiotherapy have led to the introduction of techniques such as
stereotactic body radiation therapy (SBRT), allowing the administration of ablative doses …

Purpose To evaluate the outcomes of metastasis-directed treatment (MDT) using stereotactic
body radiotherapy (SBRT) for bone-only oligometastasis (OM) detected with gallium prostate …

Background Radiotherapy is an emerging treatment strategy for nodal oligorecurrent
prostate cancer (PCa) patients. However, large heterogeneities exist in the RT regimens …